ProMIS Neurosciences is trading 10.66% higher at $10.38, with the move consistent with broader market strength; no clear company-specific catalyst has been disclosed. - Broader markets rose after weak September jobs data eased concerns about further Federal Reserve rate hikes. - The gain follows a 13.55% decline on October 1. - Its September 30 announcement listed conference appearances, including an event through October 2, but no material business development; no specific October 2 catalyst was identified.